Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Physiol Regul Integr Comp Physiol
2019 Dec 01;3176:R921-R931. doi: 10.1152/ajpregu.00190.2019.
Show Gene links
Show Anatomy links
Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.
Hull CM
,
Genge CE
,
Hobbs Y
,
Rayani K
,
Lin E
,
Gunawan M
,
Shafaattalab S
,
Tibbits GF
,
Claydon TW
.
???displayArticle.abstract???
There is significant interest in the potential utility of small-molecule activator compounds to mitigate cardiac arrhythmia caused by loss of function of hERG1a voltage-gated potassium channels. Zebrafish (Danio rerio) have been proposed as a cost-effective, high-throughput drug-screening model to identify compounds that cause hERG1a dysfunction. However, there are no reports on the effects of hERG1a activator compounds in zebrafish and consequently on the utility of the model to screen for potential gain-of-function therapeutics. Here, we examined the effects of hERG1a blocker and types 1 and 2 activator compounds on isolated zkcnh6a (zERG3) channels in the Xenopus oocyte expression system as well as action potentials recorded from ex vivo adult zebrafish whole hearts using optical mapping. Our functional data from isolated zkcnh6a channels show that under the conditions tested, these channels are blocked by hERG1a channel blockers (dofetilide and terfenadine), and activated by type 1 (RPR260243) and type 2 (NS1643, PD-118057) hERG1a activators with higher affinity than hKCNH2a channels (except NS1643), with differences accounted for by different biophysical properties in the two channels. In ex vivo zebrafish whole hearts, two of the three hERG1a activators examined caused abbreviation of the action potential duration (APD), whereas hERG1a blockers caused APD prolongation. These data represent, to our knowledge, the first pharmacological characterization of isolated zkcnh6a channels and the first assessment of hERG enhancing therapeutics in zebrafish. Our findings lead us to suggest that the zebrafish ex vivo whole heart model serves as a valuable tool in the screening of hKCNH2a blocker and activator compounds.
Arnaout,
Zebrafish model for human long QT syndrome.
2007, Pubmed,
Xenbase
Arnaout,
Zebrafish model for human long QT syndrome.
2007,
Pubmed
,
Xenbase
Aziz,
Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era.
2010,
Pubmed
Baker,
Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate.
1997,
Pubmed
Brette,
Characterization of isolated ventricular myocytes from adult zebrafish (Danio rerio).
2008,
Pubmed
Butler,
Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome.
2018,
Pubmed
Casis,
Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
2006,
Pubmed
,
Xenbase
Chaudhari,
Optimization of the adult zebrafish ECG method for assessment of drug-induced QTc prolongation.
2013,
Pubmed
Chen,
Mutations affecting the cardiovascular system and other internal organs in zebrafish.
1996,
Pubmed
Cheng,
Functional interactions of voltage sensor charges with an S2 hydrophobic plug in hERG channels.
2013,
Pubmed
,
Xenbase
Curran,
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.
1995,
Pubmed
D'Angelo,
Transgenic Galphaq overexpression induces cardiac contractile failure in mice.
1997,
Pubmed
Diness,
Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
2008,
Pubmed
Diness,
Frequency-dependent modulation of KCNQ1 and HERG1 potassium channels.
2006,
Pubmed
,
Xenbase
Gardner,
C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation.
2015,
Pubmed
,
Xenbase
Genge,
The Zebrafish Heart as a Model of Mammalian Cardiac Function.
2016,
Pubmed
Grunnet,
Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
2011,
Pubmed
,
Xenbase
Hansen,
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
2006,
Pubmed
,
Xenbase
Hassel,
Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
2008,
Pubmed
,
Xenbase
Jou,
An in vivo cardiac assay to determine the functional consequences of putative long QT syndrome mutations.
2013,
Pubmed
Kang,
Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
2005,
Pubmed
Killeen,
Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart.
2008,
Pubmed
Kramer,
Use of telemetry to record electrocardiogram and heart rate in freely moving mice.
1993,
Pubmed
Langenbacher,
Mutation in sodium-calcium exchanger 1 (NCX1) causes cardiac fibrillation in zebrafish.
2005,
Pubmed
Langheinrich,
Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia.
2003,
Pubmed
Leong,
Zebrafish as a model for long QT syndrome: the evidence and the means of manipulating zebrafish gene expression.
2010,
Pubmed
Leong,
Identification and expression analysis of kcnh2 genes in the zebrafish.
2010,
Pubmed
Lin,
Construction and use of a zebrafish heart voltage and calcium optical mapping system, with integrated electrocardiogram and programmable electrical stimulation.
2015,
Pubmed
London,
Cardiac arrhythmias: from (transgenic) mice to men.
2001,
Pubmed
Lu,
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines.
2008,
Pubmed
Mao,
Pharmacologic Approach to Defective Protein Trafficking in the E637K-hERG Mutant with PD-118057 and Thapsigargin.
2013,
Pubmed
Milan,
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization.
2009,
Pubmed
Milan,
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish.
2003,
Pubmed
Milan,
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation.
2006,
Pubmed
Nemtsas,
Adult zebrafish heart as a model for human heart? An electrophysiological study.
2010,
Pubmed
Patel,
Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome.
2008,
Pubmed
Peal,
Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen.
2011,
Pubmed
Perry,
PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance.
2009,
Pubmed
,
Xenbase
Perry,
Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
2007,
Pubmed
,
Xenbase
Perry,
A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
2008,
Pubmed
,
Xenbase
Rayani,
Zebrafish as a model of mammalian cardiac function: Optically mapping the interplay of temperature and rate on voltage and calcium dynamics.
2018,
Pubmed
Sanguinetti,
HERG1 channel agonists and cardiac arrhythmia.
2014,
Pubmed
Sanguinetti,
Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.
1990,
Pubmed
Sanguinetti,
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
1995,
Pubmed
,
Xenbase
Scholz,
Biophysical properties of zebrafish ether-à-go-go related gene potassium channels.
2009,
Pubmed
,
Xenbase
Szabó,
Enhanced repolarization capacity: new potential antiarrhythmic strategy based on HERG channel activation.
2011,
Pubmed
Taggart,
Human ventricular action potential duration during short and long cycles. Rapid modulation by ischemia.
1996,
Pubmed
Trudeau,
HERG, a human inward rectifier in the voltage-gated potassium channel family.
1995,
Pubmed
Uechi,
Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha.
1998,
Pubmed
Vornanen,
Zebrafish heart as a model for human cardiac electrophysiology.
2016,
Pubmed
Wang,
Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG.
2017,
Pubmed
Warren,
The slow mo mutation reduces pacemaker current and heart rate in adult zebrafish.
2001,
Pubmed
Wu,
Concatenated hERG1 tetramers reveal stoichiometry of altered channel gating by RPR-260243.
2015,
Pubmed
,
Xenbase
Wu,
Stoichiometry of altered hERG1 channel gating by small molecule activators.
2014,
Pubmed
,
Xenbase
Xu,
Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
2008,
Pubmed
,
Xenbase
Zhang,
Calcium handling in zebrafish ventricular myocytes.
2011,
Pubmed
Zhou,
Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity.
2005,
Pubmed
van Opbergen,
Optogenetic sensors in the zebrafish heart: a novel in vivo electrophysiological tool to study cardiac arrhythmogenesis.
2018,
Pubmed
